Acutus Medical Inc. (AFIB)
Acutus Medical Statistics
Share Statistics
Acutus Medical has 29.91M shares outstanding. The number of shares has increased by 1.62% in one year.
Shares Outstanding | 29.91M |
Shares Change (YoY) | 1.62% |
Shares Change (QoQ) | 0.19% |
Owned by Institutions (%) | 0.01% |
Shares Floating | 24.31M |
Failed to Deliver (FTD) Shares | 1.76K |
FTD / Avg. Volume | 4.44% |
Short Selling Information
The latest short interest is 553.6K, so 1.86% of the outstanding shares have been sold short.
Short Interest | 553.6K |
Short % of Shares Out | 1.86% |
Short % of Float | 2.04% |
Short Ratio (days to cover) | 0.68 |
Valuation Ratios
The PE ratio is -0.17 and the forward PE ratio is -0.03. Acutus Medical's PEG ratio is 0.
PE Ratio | -0.17 |
Forward PE | -0.03 |
PS Ratio | 0.08 |
Forward PS | 0 |
PB Ratio | -0.14 |
P/FCF Ratio | -0.05 |
PEG Ratio | 0 |
Enterprise Valuation
Acutus Medical Inc. has an Enterprise Value (EV) of 18.15M.
EV / Earnings | -1.9 |
EV / Sales | 0.9 |
EV / EBITDA | 8.07 |
EV / EBIT | -318.48 |
EV / FCF | -0.57 |
Financial Position
The company has a current ratio of 2.06, with a Debt / Equity ratio of -3.09.
Current Ratio | 2.06 |
Quick Ratio | 1.91 |
Debt / Equity | -3.09 |
Total Debt / Capitalization | 147.96 |
Cash Flow / Debt | -0.89 |
Interest Coverage | -0.01 |
Financial Efficiency
Return on equity (ROE) is 0.82% and return on capital (ROIC) is -0.24%.
Return on Equity (ROE) | 0.82% |
Return on Assets (ROA) | -0.33% |
Return on Capital (ROIC) | -0.24% |
Revenue Per Employee | $237,141.18 |
Profits Per Employee | $-112,317.65 |
Employee Count | 85 |
Asset Turnover | 0.7 |
Inventory Turnover | 10.69 |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -73.4% in the last 52 weeks. The beta is -0.13, so Acutus Medical's price volatility has been lower than the market average.
Beta | -0.13 |
52-Week Price Change | -73.4% |
50-Day Moving Average | 0.05 |
200-Day Moving Average | 0.06 |
Relative Strength Index (RSI) | 46.09 |
Average Volume (20 Days) | 39.76K |
Income Statement
In the last 12 months, Acutus Medical had revenue of 20.16M and earned -9.55M in profits. Earnings per share was -0.32.
Revenue | 20.16M |
Gross Profit | 1.01M |
Operating Income | -57K |
Net Income | -9.55M |
EBITDA | 2.25M |
EBIT | -57K |
Earnings Per Share (EPS) | -0.32 |
Balance Sheet
The company has 14.02M in cash and 35.76M in debt, giving a net cash position of -21.75M.
Cash & Cash Equivalents | 14.02M |
Total Debt | 35.76M |
Net Cash | -21.75M |
Retained Earnings | -609.52M |
Total Assets | 28.65M |
Working Capital | 13.14M |
Cash Flow
In the last 12 months, operating cash flow was -31.66M and capital expenditures -112K, giving a free cash flow of -31.77M.
Operating Cash Flow | -31.66M |
Capital Expenditures | -112K |
Free Cash Flow | -31.77M |
FCF Per Share | -1.07 |
Margins
Gross margin is 5.03%, with operating and profit margins of -0.28% and -47.36%.
Gross Margin | 5.03% |
Operating Margin | -0.28% |
Pretax Margin | -22.5% |
Profit Margin | -47.36% |
EBITDA Margin | 11.16% |
EBIT Margin | -0.28% |
FCF Margin | -157.62% |
Dividends & Yields
AFIB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -640% |
FCF Yield | -2042.64% |
Analyst Forecast
Currently there are no analyst rating for AFIB.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | -28.37 |
Piotroski F-Score | 3 |